Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by wexworthon Nov 13, 2020 3:03pm
107 Views
Post# 31896739

RE:RE:Posted message german board

RE:RE:Posted message german board
then how do you explain why we went from mid twenties up to 34 cents when early speculation was that a rodan launch was imminent in October? if it had of gone, I believe we would be trading in mid 40s, minimum. its more than just a financial statement. In Sirona's case, the product launch, when it happens, that the tap is turned on and I think we are going to be pleasantly surprised at the product volume and market profile we may get...Aurora Cannabis jumped from the 8$ range to $15 in two days over the possibility that Biden would be elected. Then they sh!t their pants and did a public offering at $7.50, only to start climbing back up right away...My point is that the market works on the probability of future earnings and commercial possibility, not just sales next quarter. Its called Value.
<< Previous
Bullboard Posts
Next >>